Menu

• Ask a Health Expert about FACIAL NERVE DISORDER
• Post Your Side Effect related to FACIAL NERVE DISORDER
• FACIAL NERVE DISORDER and FDA Warnings
• FACIAL NERVE DISORDER in Patients Wiki
• Report FACIAL NERVE DISORDER in Drug Side Effect Survey

FACIAL NERVE DISORDER side effect

What is FACIAL NERVE DISORDER ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Byetta Side Effects Report #5359807-9
Consumer or non-health professional from UNITED STATES reported BYETTA problem on Mar 16, 2007. Female patient, 62 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: facial nerve disorder, weight decreased, . BYETTA dosage: unknown. Patient recovered.

Cosopt Side Effects Report #5624757-7
COSOPT problem was reported by a Physician from TUNISIA on Feb 07, 2008. Female patient, 30 years of age, was diagnosed with post procedural complication and was treated with COSOPT. After drug was administered, patient experienced the following problems/side effects: convulsion, facial nerve disorder, neuralgia, paraesthesia, . COSOPT dosage: unknown. During the same period patient was treated with SOLUPRED, MAXIDROL, TROPICAMIDE, OFLOXACIN. Patient recovered.

Sandimmune Side Effects Report #5442987-4
Physician from GERMANY reported SANDIMMUNE problem on Aug 28, 2007. Female patient was diagnosed with liver transplant and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: depression, facial nerve disorder, intestinal perforation, menstrual disorder, non-hodgkin's lymphoma, oedema, portal shunt, sinusitis, small intestinal resection, . SANDIMMUNE dosage: unknown. During the same period patient was treated with FLUOXETINE, DOPASTON. Patient was hospitalized. Patient recovered.

Natalizumab Side Effects Report #5397315-X
NATALIZUMAB problem was reported by a Physician from GREECE on July 13, 2007. Female patient, 33 years of age, weighting 127.9 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: dysarthria, facial nerve disorder, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.


Natalizumab Side Effects Report #5397315-X
Physician from GREECE reported NATALIZUMAB problem on July 13, 2007. Female patient, 33 years of age, weighting 127.9 lb, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: dysarthria, facial nerve disorder, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.